Get the Stockscreener App
2.67
4.71%
0.12
After Hours:
2.67
Achieve Life Sciences Inc stock is traded at $2.67, with a volume of 540.96K.
It is up +4.71% in the last 24 hours and up +18.14% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$2.55
Open:
$2.59
24h Volume:
540.96K
Relative Volume:
0.66
Market Cap:
$92.61M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.4054
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-2.20%
1M Performance:
+18.14%
6M Performance:
-17.59%
1Y Performance:
-45.84%
1-Day Range:
$2.53
$2.71
1-Week Range:
$2.53
$2.77
52-Week Range:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.67 | 133.65M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Can Traders Expect Breakout From Achieve Life Sciences Inc. This WeekStock Screener With Smart Filters Highlights Top Picks - metal.it
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire
Achieve Life Sciences to Participate in BTIG Virtual Biotechnology Conference on July 29-30, 2025 - Quiver Quantitative
Achieve Life Sciences Reveals Latest Progress on Revolutionary Smoking Cessation Drug at BTIG Biotech Conference - Stock Titan
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionRisk Adjusted Technical Entry Plan Gains Followers - metal.it
Momentum Screeners Rank Achieve Life Sciences Inc. in Top 5 TodayVerified Signal From Chart Patterns Detected - metal.it
Published on: 2025-07-28 20:18:34 - metal.it
How strong is Achieve Life Sciences Inc. company’s balance sheetAchieve consistent double-digit returns - jammulinksnews.com
Market reaction to Achieve Life Sciences Inc.’s recent newsShort-Term Growth Watch with Signal Prediction - Newser
Sector ETF performance correlation with Achieve Life Sciences Inc.Reversal Signal Prediction Based on Volume - Newser
What are the latest earnings results for ReShape Lifesciences Inc.Achieve breakthrough profits with smart strategies - jammulinksnews.com
What is the dividend policy of Kezar Life Sciences Inc. stockAchieve exceptional returns with expert guidance - jammulinksnews.com
Has Achieve Life Sciences Inc. found a price floor Loss Limitation Strategy Based on Analysis - Newser
How to forecast Achieve Life Sciences Inc. trends using time series Smart Entry Watchlist with Daily Analysis - Newser
How to forecast Achieve Life Sciences Inc. trends using time series Daily Equity Signal Strength Summary Report - Newser
What are the technical indicators suggesting about Achieve Life Sciences Inc.AI Powered Tips For 2025 - jammulinksnews.com
Does TriSalus Life Sciences Inc. stock perform well during market downturnsAchieve consistent profits with smart trading - jammulinksnews.com
Is Kezar Life Sciences Inc. stock overvalued or undervaluedAchieve breakthrough profits with expert advice - jammulinksnews.com
How Efficient Is Achieve Life Sciences Inc. at Controlling Operating CostsMomentum Swing Watchlist - metal.it
What makes Achieve Life Sciences Inc. stock price move sharplyMassive stock growth - jammulinksnews.com
How does ReShape Lifesciences Inc. generate profit in a changing economyAchieve impressive returns with smart timing - jammulinksnews.com
What are Achieve Life Sciences Inc. company’s key revenue driversGet high-impact stock recommendations now - jammulinksnews.com
How does Achieve Life Sciences Inc. compare to its industry peersFastest return on investment - jammulinksnews.com
Is Achieve Life Sciences Inc. stock overvalued or undervaluedExceptional profit velocity - jammulinksnews.com
Achieve Life Sciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Community with 300% Return - Newser
How Interest Rate Changes Impact Achieve Life Sciences Inc. Stock PerformanceLow Drawdown Trade Signals - Newser
New Product Launches: Will They Boost Achieve Life Sciences Inc. Stock in 2025Free Stock Trading Community - Newser
Key External Factors That Drive Achieve Life Sciences Inc. Stock Price MovementsParabolic Move Ideas - Newser
What makes Achieve Life Sciences Inc. stock attractive to long term investorsTop Momentum Stock Pick - Newser
Achieve Life Sciences Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia
What drives Achieve Life Sciences Inc. stock priceDouble-digit growth - Autocar Professional
Achieve Life Sciences to Announce Second Quarter Financial - GlobeNewswire
Achieve Life Sciences to Update Investors on Smoking Cessation Drug Progress in Q2 Earnings Call - Stock Titan
Is Achieve Life Sciences Inc. a good long term investmentBreakneck growth rates - jammulinksnews.com
What analysts say about Achieve Life Sciences Inc. stockStrong return on assets - jammulinksnews.com
Will Achieve Life Sciences Inc. stock split in the near futureFree Stock Selection - Newser
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
0.23%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):